ArticleAmerican journal of preventive cardiology2024

Glucagon-like peptide-1 receptor agonist and sodium-glucose cotransporter 2 inhibitor use among adults with diabetes mellitus by cardiovascular-kidney disease risk: National Health and Nutrition Examination Surveys, 2015-2020.

Joshua A Jacobs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.